Home
>
National Drug Code (NDC)
>
Hydralazine Hydrochloride
Hydralazine Hydrochloride - 50111-327-03 - (Hydralazine Hydrochloride)
Drug Information of Hydralazine Hydrochloride
| Product NDC: | 50111-327 |
| Proprietary Name: | Hydralazine Hydrochloride |
| Non Proprietary Name: | Hydralazine Hydrochloride |
| Active Ingredient(s): | 25 mg/1 & nbsp; Hydralazine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Hydralazine Hydrochloride
| Product NDC: | 50111-327 |
| Labeler Name: | Pliva Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA088467 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19900930 |
Package Information of Hydralazine Hydrochloride
| Package NDC: | 50111-327-03 |
| Package Description: | 1000 TABLET in 1 BOTTLE (50111-327-03) |
NDC Information of Hydralazine Hydrochloride
| NDC Code | 50111-327-03 |
| Proprietary Name | Hydralazine Hydrochloride |
| Package Description | 1000 TABLET in 1 BOTTLE (50111-327-03) |
| Product NDC | 50111-327 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydralazine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19900930 |
| Marketing Category Name | ANDA |
| Labeler Name | Pliva Inc. |
| Substance Name | HYDRALAZINE HYDROCHLORIDE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |
